secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001641172-25-014899
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 3.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech completes 1-for-100 reverse split; regains NYSE American listing compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-100 ratio effective June 12, 2025; new CUSIP 00901B303.
- NYSE American withdrew delisting determination; trading resuming June 17, 2025 under symbol AIM.
- Stock traded on OTC Pink (AIMID) during suspension; now reinstated on NYSE American.
- Reverse split authorized by stockholders Apr 30, 2025; Board fixed ratio May 29, 2025.
- Cash paid for fractional shares post-split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000164117225014899/0001641172-25-014899-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000164117225014899/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-014899

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer